Figure 1a. Bioflux 200 system installed in the laboratory
 |
Figure 1b. Two wells of a Bioflux 48-well plate connected by a microchannel. We grow a confluent layer of
endothelial cells in a viewing portion of the microchannel
 |
Figure 2. VECAM simulation of active deformation of the cell during its entrance into a pore of a square cross section
 |
Figure 3. Static adhesion data showing synergy betwen TNF-alpha and histamine in THP-1 monocytic cell adhesion to HUVEC
 |
Figure 4. Phase-constrast images showing adhesion of GP Ibalpha-coated microbeads (A,B) and platelets (C,D) to resting and histamine-stimulated HUVEC
 |
|
Project 1. Quantitative Biomechanical Models of Circulating Cell Interactions
with Applications in Inflammation, Atherosclerosis, Thrombosis, Sickle Cell Disease, and
Cancer Metastasis
Funding: Skolkovo Foundation, Louisiana Board of Regents, Newcomb College Institute
Students involved: Hongzhi Lan (leukocyte migration modeling),
Carol Chen (experimental work: leukocyte and tumor cell adhesion assays),
Gisele Calderon (experiments on breast cancer cell interactions with monocytic and endothelial cells),
You Lu (modeling thrombus formation and rupture),
Teddy Brown and Sabrina Lynch (experimental work: platelet adhesion),
Zerick Dunbar (experimental work: sickle cell adhesion)
Inflammation. Blood-borne leukocytes (white blood cells) are the first
line of defense against invading pathogens. They are recruited from peripheral
blood into infected tissues during inflammation through a complex series of
events involving leukocyte capture by activated endothelial cells, leukocyte
rolling on and firm adhesion to endothelium, and leukocyte transendothelial
migration (diapedesis). These events, collectively known as leukocyte extravasation or leukocyte adhesion
cascade, are mediated by the interplay of inflammatory mediators and cell
adhesion molecules of the selectin and integrin families. In our laboratory,
we study the leukocyte adhesion cascade by using in vitro systems
(a parallel-plate flow chamber and
Bioflux 200 microfluidic shear flow system that permits up to 24 cell
adhesion assays in parallel, Fig. 1) and our custom three-dimensional computational
algoritm of deformable cell adhesion, known as VECAM (ViscoElastic Cell Adhesion Model). VECAM can predict both
passive and active deformation of adherent cells (Fig. 2) as well as cell adhesion to a compliant substrate.
Understanding the leukocyte adhesion cascade is critical to the development of therapies
for inflammatory disorders.
Atherosclerosis, a leading cause of myocardial infarction and stroke, is
now recognized as a chronic inflammation in the walls of arteries. This condition
develops as a result of oxidative damage to vascular endothelium, leading to
increased adhesion of monocytes to endothelial cells and accumulation of
monocytes/macrophages in the intimal layer of the arterial wall. To identify
proatherogenic factors (chemicals, flow disturbances) and thus to develop the
therapy targeted to atherosclerosis, we study adhesive interactions of human
monocytes with human vascular endothelial cells activated by a combination of factors such as
oxidized low-density lipoprotein (OxLDL), TNF-alpha, histamine, LPS, and serotonin. We are interested to understand
the interplay between mediators released from tissue resident macrophages and mast cells in
the development of cardiovascular disease. Our preliminary study indicate a synergy between TNF-alpha (released from macrophages) and
histamine (released from mast cells) in monocyte-endothelium adhesion (Fig. 3). In this effort, we collaborate with Prof. D. Neil Granger
(LSU Health Sciences Center at Shreveport).
Thrombosis. The adhesion and accumulation of platelets (thrombocytes) on collagen at a site of vascular injury result
in a blood clot that seals the injured vessel. However, interactions of platelets with intact but dysfunctional endothelium
cause the formation of a thrombus that occludes the blood flow. Arterial thrombosis developed at atherosclerotic plaques in
large vessels supplying oxygen to the heart and brain is especially dangerous. This is because it may lead to the rupture of
the plaque from underlying tissue and blockage of arteries downstream, thus causing myocardial infarction or stroke.
Our interests are in understanding how inflammatory mediators (e.g., histamine and TNF-alpha) influence platelet adhesion to vascular endothelium (Fig. 4) and
subsequent growth of a thrombus.
Sickle cell disease. Red blood cells that carry oxygen to distant tissues in the body becomes more rigid and sticky and change their shape in patients
with sickle cell disease (SCD) due to aggregation of the abnormal hemoglobin molecules (hemoglobin-S) inside the cells. Interactions of sickle red blood cells
with vascular endothelial cells and leukocytes are the main reason why SCD patients have severe vaso-occlusive pain episodes and low life expectancy. We study
these interactions using our microfluidic flow systems and computational modeling.
Cancer Metastasis. Tumor cells switch to a motile, metastatic phenotype when they break away from their primary tumor. This leads to their migration into
blood or lymphatic vessels (intravasation) and then to their interactions with the endothelium and migration across the endothelium into tissue at distant sites
(extravasation), where tumor cells form metastases. We conduct both experimental and computational studies to elucidate the factors that influence
the interactions of circulating tumor cells with leukocytes and vascular and lymphatic endothelium.
|